VMPIC
Varma Mutual Pension Insurance Co Portfolio holdings
AUM
$13.6B
1-Year Return
18.68%
This Quarter Return
-12.34%
1 Year Return
+18.68%
3 Year Return
+84.91%
5 Year Return
+154.83%
10 Year Return
–
AUM
$3.34B
AUM Growth
-$1.84B
(-36%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-35.84%
Top 10 Holdings %
Top 10 Hldgs %
80.9%
Holding
99
New
27
Increased
9
Reduced
33
Closed
11
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$711M |
| 2 |
iShares MSCI China ETF
MCHI
|
+$96.1M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$48.9M |
| 4 |
iShares MSCI Hong Kong ETF
EWH
|
+$42M |
| 5 |
Procter & Gamble
PG
|
+$17.2M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$521M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$483M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$343M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$333M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$138M |
Sector Composition
| 1 | Technology | 6.32% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 2.15% |
| 4 | Consumer Staples | 2.05% |
| 5 | Consumer Discretionary | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$288B
| $12.2M | 0.36% |
+275,350
| New | +$12.2M |
|
27
PepsiCo
PEP
$197B
| $11.7M | 0.35% |
+97,511
| New | +$11.7M |
|
28
Merck
MRK
$207B
| $11.5M | 0.35% |
157,200
| – | – |
|
29
Home Depot
HD
$421B
| $11.4M | 0.34% |
+61,048
| New | +$11.4M |
|
30
Eli Lilly
LLY
$677B
| $9.71M | 0.29% |
70,000
+25,000
| +56% | +$3.47M |
|
31
AbbVie
ABBV
$386B
| $9.14M | 0.27% |
120,000
+20,000
| +20% | +$1.52M |
|
32
iShares MSCI Canada ETF
EWC
$3.26B
| $8.87M | 0.27% |
406,000
| – | – |
|
33
Amazon
AMZN
$2.43T
| $8.64M | 0.26% |
+88,620
| New | +$8.64M |
|
34
Bristol-Myers Squibb
BMY
$94B
| $8.36M | 0.25% |
150,000
| – | – |
|
35
Zebra Technologies
ZBRA
$15.9B
| $7.98M | 0.24% |
+43,456
| New | +$7.98M |
|
36
Abbott
ABT
$233B
| $7.89M | 0.24% |
100,000
-50,000
| -33% | -$3.95M |
|
37
Dollar General
DG
$23B
| $7.26M | 0.22% |
+48,080
| New | +$7.26M |
|
38
Pfizer
PFE
$136B
| $7.18M | 0.22% |
231,880
-52,700
| -19% | -$1.63M |
|
39
Vertex Pharmaceuticals
VRTX
$101B
| $7.14M | 0.21% |
+30,000
| New | +$7.14M |
|
40
Thermo Fisher Scientific
TMO
$181B
| $7.09M | 0.21% |
+25,000
| New | +$7.09M |
|
41
Danaher
DHR
$136B
| $7.06M | 0.21% |
57,528
-57,528
| -50% | -$7.06M |
|
42
Kimberly-Clark
KMB
$42.5B
| $6.77M | 0.2% |
+52,931
| New | +$6.77M |
|
43
BioMarin Pharmaceuticals
BMRN
$10.4B
| $6.76M | 0.2% |
80,000
+30,000
| +60% | +$2.54M |
|
44
Fidelity National Information Services
FIS
$34.9B
| $6.75M | 0.2% |
55,500
-19,500
| -26% | -$2.37M |
|
45
Gilead Sciences
GILD
$142B
| $6.73M | 0.2% |
90,000
-60,000
| -40% | -$4.49M |
|
46
Meta Platforms (Facebook)
META
$1.9T
| $6.67M | 0.2% |
40,000
-10,000
| -20% | -$1.67M |
|
47
Biogen
BIIB
$21.2B
| $6.33M | 0.19% |
20,000
-10,000
| -33% | -$3.16M |
|
48
Amgen
AMGN
$149B
| $6.08M | 0.18% |
30,000
-10,000
| -25% | -$2.03M |
|
49
Accenture
ACN
$149B
| $5.99M | 0.18% |
36,690
-9,460
| -20% | -$1.54M |
|
50
Zoetis
ZTS
$65.7B
| $5.88M | 0.18% |
50,000
-80,000
| -62% | -$9.41M |
|